logo
  1. Home
  2. Stocks
  3. Orchid Pharma

Orchid Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: ORCHPHARMA | BSE: 524372

₹756.15 image-39.80 (-5.00 %)

Last Updated: 04 Apr 2025 03:46 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 808.00

High (₹) 808.95

Low (₹) 756.15

Prev. Close (₹) 795.95

Volume 51,274

VWAP (₹) 936.02

ROCE (%) 8.37

Industry P/E 44.73

TTM P/E 34.77

P/B Ratio 3.28

Market Cap (₹) Cr.3,835.13

Dividend Yield (%)--

EPS (₹) 19.06

ROE8.27%

Sales Growth (%) 23.05

Profit Growth (%)96.12

Day Range

808.95808.95

L
H

52 Week Range

757.501,998.00

L
H

Historical Returns

Returns (6M)

-39.88 %

Returns (1Y)

-32.56 %

Returns (3Y)

118.16 %

Returns (5Y)

4100.83 %

Returns (6M)

-39.88 %

Returns (1Y)

-32.56 %

Returns (3Y)

118.16 %

Returns (5Y)

4100.83 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (67.93%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 67.93% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Positive ROC (9) indicates upward momentum.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 35.59

MFI 8.27

ATR 88.86

Commodity Channel Index -55.11

ROC125 -31.56

ROC21 -31.08

Williams %R -73.62

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current990.761,020.481,059.01952.23922.51883.98854.26
Week Ago933.39948.52978.79903.12887.99857.72842.59
Month Ago1,411.741,487.071,549.291,349.521,274.191,211.971,136.64

EMA & SMA
info_icon

756.15

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 948.42

9 Day 898.07

10 Day 919.05

12 Day 1012.32

14 Day 1038.26

20 Day 1151.87

26 Day 1211.21

50 Day 1470.47

100 Day 1468.32

200 Day 1365.66

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
29 Nov, 2023DHANUKA LABORATORIES LIMITEDDisposal₹571.2813,00,000NSE
25 Jan, 2022Dhanuka Laboratories LimitedRevoke₹387.0580,00,015NSE
21 Jan, 2022Dhanuka Laboratories LimitedRevoke₹415.401,20,00,022NSE
03 Jul, 2021Dhanuka Laboratories LimitedPledge₹916.661,20,00,022NSE
27 Jun, 2021M/s Dhanuka Laboratories LimitedDisposal₹488.2832,80,115NSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
29 Mar, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange about the Letter(s)/emails received from stock exchanges as Cautionary under SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015
29 Mar, 2025BSE IndiaIntimation of Letters/emails received from Stock Exchanges as Cautionary under SEBI Listing Regulations, 2015.
27 Mar, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange about Closure of Trading Window
27 Mar, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
10 Mar, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange regarding ''Intimation related to the Scheme of Amalgamation of Dhanuka LaboratoriesLimited ( Amalgamating Company ) with Orchid Pharma Limited ( Company / Amalgamated Company ) and their respective shareholders and creditors( the Scheme ) under Regulation 30 of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015, as amended''.
10 Mar, 2025BSE IndiaUpdate on Scheme of Amalgamation of Dhanuka Laboratories Limited (\Amalgamating Company\) with Orchid Pharma Limited (\Company\/\Amalgamated Company\) and their respective Shareholders and Creditors.\r\n
07 Mar, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange about Credit Rating
07 Mar, 2025BSE IndiaReview of Credit Rating of Orchid Pharma Limited
28 Feb, 2025BSE IndiaDisclosure regarding the Order passed by Goods & Service Tax Department
28 Feb, 2025NSE IndiaOrchid Pharma Limited has informed the Exchange about Action(s) taken or orders passed

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--07 Feb, 202512 Feb, 2025
Quarterly Results--06 Nov, 202411 Nov, 2024
Quarterly Results--07 Aug, 202412 Aug, 2024
Audited Results--20 May, 202423 May, 2024
Quarterly Results--05 Feb, 202408 Feb, 2024
Quarterly Results--31 Oct, 202304 Nov, 2023
Quarterly Results--07 Aug, 202310 Aug, 2023
Audited Results--04 May, 202310 May, 2023
Quarterly Results--06 Feb, 202309 Feb, 2023
OthersInter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis.29 Nov, 202201 Dec, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group69.84%69.84%89.96%90%98.07%
Foreign Institutions +2.53%4.14%0.86%1.78%0.01%
Domestic Institutions +19%14.51%3.94%3.35%1.05%
Government0%0%0%0%0%
Public8.63%11.51%5.24%4.87%0.87%
Others0%0%0%0%0%

About Orchid Pharma

Orchid Pharma is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 819.37 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Dhanuka Group

Founded

1992

Managing Director

Mr. Manish Dhanuka

NSE Symbol

ORCHPHARMA

Orchid Pharma Management

NameDesignation
Mr. Ram Gopal AgarwalChairman & Non-Exe.Director
Mr. Manish DhanukaManaging Director
Mr. Mridul DhanukaWhole Time Director
Mr. Arjun DhanukaNon Executive Director
Mrs. Tanu SinglaIndependent Director
Dr. Dharam VirIndependent Director
Mr. Manoj Kumar GoyalIndependent Director
Ms. Shubha SinghIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Orchid Pharma

What is the share price of Orchid Pharma?

The share price of Orchid Pharma on 04 Apr, 2025 is ₹ 756.15.

What is 52W high and 52W low share price of Orchid Pharma?

The highest and lowest 52W share prices of Orchid Pharma are ₹ 1998.000 and ₹ 760.050

What is the market cap of Orchid Pharma?

The market capitalization of Orchid Pharma as of 04 Apr, 2025 is ₹ 3,835.13 Crores

What is the P/E ratio of Orchid Pharma?

The current P/E ratio of Orchid Pharma as of 04 Apr, 2025 is 44.73

What is the PB ratio of Orchid Pharma?

The PB ratio of Orchid Pharma as of 04 Apr, 2025 is 3.28

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited